the potential of stromal vascular fraction (SVF) cell
therapy as a novel regenerative treatment for ICH. SVF
WANG, K.,
LIU, H.,
LIU, J.,
WANG, X.,
TENG, L.,
ZHANG, J.,
CHEN, X.,
WANG, N.,
ZHONG, Y.,
HOU, X.,
JIANG, H.,
ZHANG, X.,
ZHAO, S.,
LIU, Y.,
YAO, Y.,
WANG, J.,
QU, Y.,
PENG, F.,
BEYLERLI, O.,
LIAO, X. (2019) that targeting amino acid metabolism such as methionine deprivation/IL1RN related gene
therapy may offer novel
GAREEV, I.F.,
BEILERLI, O.A.,
ALIEV, G.M.,
PAVLOV, VALENTIN,
IZMAILOV, ADEL,
ZHANG, YIWEI,
LIANG, YANCHAO,
YANG, GUANG (2020) aneurysms will have the potential to use lncRNAs in
therapy, as well as in the diagnosis and prediction
BEYLERLI, OZAL,
BEERAKA, NARASIMHA M.,
GAREEV, ILGIZ,
PAVLOV, VALENTIN,
YANG, GUANG,
LIANG, YANCHAO,
ALIEV, GJUMRAKCH (2020) neoplastic transformation.
Therapy of PAs with aggressive behavior is a complex task. When surgery
The question of what came first—in this case the diagnosis of prostate cancer or its
therapySharipov, R.A.,
Omarov, M.A.,
Mulyukov, A.R.,
Dybova, A.I.,
Vyaseleva, E.T.,
Kayumova, N.B.,
Saitgalina, A. Sh.,
Ententeev, K.R.,
Iagafarov, I.R.,
Kuserbaev, I.V.,
Gubaeva, E.A. (2023) of gene
therapy methods and attracted the attention of the entire scientific community. This technology
therapy with miRNA to improve the prognosis of patients with this pathology. © 2022 The Authors